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January 1999
Dear Colleague,
The ISPOR Inaugural European Conference, held December 10–12, 1998 in Cologne, Germany, was an 
overwhelming success. We are extremely pleased to have had as co-sponsor of this event, the University of 
Cologne. Thanks to the diligent efforts of Professor Karl Lauterbach and other members of his team at the 
Institute for Health Economics at the University of Cologne, our first conference in Europe was a great success.
We also thank the other co-chairs of the planning committee, Peter Davey MD, FRCP, Jonathan Cooke MPharm, 
PhD, and Alan Hillman MD, MPH for their commitment and dedication in making this conference a success.
We are extremely pleased with the cooperation from the European health economic academic community in the 
preparation of this exciting invited presentation program and the response from the European health economic 
research community to our contributed presentation program.
The mission of the International Society for Pharmacoeconomics and Outcomes Research is to translate 
pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce healthcare 
resources wisely, fairly, and efficiently. Information comparing the expected gains of a medical intervention against 
the expected cost of that intervention versus other healthcare interventions are, many times, difficult to interpret 
or compare. The goal of this conference was to provide a forum for researchers and practitioners to 
communicate needs and concerns as consensus is developed on methodology, interpretation, and use of 
pharmacoeconomic information.
To continue our efforts to globalize our Society, the ISPOR European Conference will be an annual event. Next 
year’s conference will be November 11–13, 1999 at the Sheraton Hotel, Edinburgh, Scotland.
I hope to see you there.
Sincerely,
Robert S. Epstein MD, MS
1998–1999 ISPOR President
